SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based Illumina has teamed up with German-based Merck Serono and Australia-based Genea to form a consortium known as Global Fertility Alliance for Excellence in Assisted Reproductive Treatment.
San Diego’s Orexigen Therapeutics Inc. and its partner, Takeda Pharmaceuticals, have filed a lawsuit against Actavis Laboratories FL Inc., Andrx Corp., Actavis Pharma Inc., and Actavis Inc., collectively referred to as Actavis.
Halozyme Therapeutics Inc., an oncology biotech in San Diego, reported that its chief financial officer, David Ramsay, will retire this summer.
BIOTECH: The Company Specializes in Forensics, Diagnostics
Diomics Inc. announced recently that Stephen Slick, a former CIA clandestine service senior official, has joined the company’s board of directors.
MEDICINE: Stops Include More Isolated Areas of the Region
When the words “mobile health” are spoken in today’s high-tech economy, people are usually referring to smartphone apps and wearable technology. Kaiser Permanente had a more literal approach.
BIOTECH: Adds Staff, Uplists to Nasdaq Prior to Phase 2
OncoSec Medical Inc., a public biotech company that’s operated largely under the radar in San Diego, has uplisted to the Nasdaq in a move to attract investors with more weight.
Pure Bioscience Inc., creator of an antimicrobial that can be sprayed directly on food to kill harmful bacteria, announced that the company intends to resubmit its Food Contact Notification to the FDA for use of its SDC antimicrobial in raw poultry processing before the end of June.
AMN Healthcare announced that it has named industry veteran Darren Findley as vice president of recruitment process outsourcing.
Kleanthis Xanthopoulos, who has served more than seven years at the helm of San Diego microRNA drug developer Regulus Therapeutics, unexpectedly resigned as CEO and from the company’s board, according to a statement from the company.
Neurocrine Biosciences Inc. announced that Eric Benevich has joined the company as chief commercial officer.
Biocept Inc., a molecular diagnostics company developing liquid biopsies to improve the detection and treatment of cancer, entered into a clinical collaboration with Sarah Cannon Research Institute, the research arm of Sarah Cannon, the global cancer enterprise of Hospital Corp. of America.
Poseida Therapeutics Inc., a privately-held human therapeutics spinoff of Transposagen Biopharmaceuticals Inc., announced it has begun drug development operations at its new location at Johnson & Johnson Innovation, JLABS in San Diego.
La Mesa-based Entest BioMedical Inc. announced Tuesday that the company is in discussions to acquire a nanotechnology for the delivery of cancer therapeutics in both animals and humans.
San Diego-based Benefunder announced a partnership with Washington D.C.-based Children’s National Health System to boost funding for pediatric research.
San Diego drug developer Celladon Corp. has announced new leadership and plans to seek an acquisition or partnership.